BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2995691)

  • 21. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection.
    Biggar RJ; Henle W; Fleisher G; Böcker J; Lennette ET; Henle G
    Int J Cancer; 1978 Sep; 22(3):239-43. PubMed ID: 212369
    [No Abstract]   [Full Text] [Related]  

  • 24. [Etiological factors in Burkitt's disease].
    Capdevielle P; Darie H; Barabé P
    Med Trop (Mars); 1983; 43(3):227-33. PubMed ID: 6310311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control.
    Gunapala DE; Facer CA; Davidson R; Weir WR
    Parasitol Res; 1990; 76(6):531-5. PubMed ID: 2166284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus, malaria and endemic Burkitt lymphoma.
    Velavan TP
    EBioMedicine; 2019 Jan; 39():13-14. PubMed ID: 30584007
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
    Magrath IT; Henle W
    IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
    [No Abstract]   [Full Text] [Related]  

  • 28. Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa.
    Biggar RJ; Gardiner C; Lennette ET; Collins WE; Nkrumah FK; Henle W
    Lancet; 1981 Jul; 2(8238):115-8. PubMed ID: 6113482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chloroquine on Epstein-Barr virus expression.
    Lenoir G; Geser A
    Nature; 1979 Dec; 282(5740):758. PubMed ID: 229421
    [No Abstract]   [Full Text] [Related]  

  • 30. Endemic Burkitt lymphoma - an aggressive childhood cancer linked to Plasmodium falciparum exposure, but not to exposure to other malaria parasites.
    Quintana MDP; Smith-Togobo C; Moormann A; Hviid L
    APMIS; 2020 Feb; 128(2):129-135. PubMed ID: 32133709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New oncologic associations for the Epstein-Barr virus.
    Gartner JG; Seemayer TA
    Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684
    [No Abstract]   [Full Text] [Related]  

  • 32. [The Epstein-Barr Virus and Infectious Mononucleosis. Findings, interpretations, and an alternative hypothesis on the direct etiology by the Epstein-Barr Virus].
    Gsell HO
    Schweiz Med Wochenschr; 1971 Jun; 101(23):841-8. PubMed ID: 4325374
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion.
    Biggar RJ; Henle G; Böcker J; Lennette ET; Fleisher G; Henle W
    Int J Cancer; 1978 Sep; 22(3):244-50. PubMed ID: 212370
    [No Abstract]   [Full Text] [Related]  

  • 34. [Theory and practice of the serology of Epstein-Barr virus].
    Seigneurin JM; Lenoir GM
    Dev Biol Stand; 1982; 52():205-19. PubMed ID: 6299831
    [No Abstract]   [Full Text] [Related]  

  • 35. Epstein-Barr virus infections in childhood.
    Oberender H; Graessner U; Falkenhagen U; Kunkel M; Gärtner L; Kupatz H; Schumacher K
    Acta Virol; 1979 Mar; 23(2):137-42. PubMed ID: 39436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epstein-Barr virus as an etiological factor in infectious mononucleosis and other diseases].
    Kacprzak-Bergman I; Rudkowski Z
    Pediatr Pol; 1977 Nov; 52(11):1293-7. PubMed ID: 201912
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.
    Moss DJ; Burrows SR; Castelino DJ; Kane RG; Pope JH; Rickinson AB; Alpers MP; Heywood PF
    Int J Cancer; 1983 Jun; 31(6):727-32. PubMed ID: 6305850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE; Giraudo Conesa LC; Braun M
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract]   [Full Text] [Related]  

  • 39. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.
    Moormann AM; Chelimo K; Sumba PO; Tisch DJ; Rochford R; Kazura JW
    J Infect Dis; 2007 Mar; 195(6):799-808. PubMed ID: 17299709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.